1. Dec. 15, 2021

    Fertility preservation for transgender individuals

    Zaraq Khan, M.B.B.S., reviews fertility preservation options for transgender individuals as discussed in an article he and colleagues published in the April 2020 issue of Mayo Clinic Proceedings.

  2. Dec. 15, 2021

    Fertility preservation in women and girls

    Zaraq Khan, M.B.B.S., discusses fertility preservation options presented in a paper he and colleagues published in the April 2020 issue of Mayo Clinic Proceedings.

  3. Dec. 15, 2021

    Beyond reflexive and prophylactic gynecologic surgery

    Elizabeth (Ebbie) A. Stewart, M.D., discusses a review paper she and colleagues published in Mayo Clinic Proceedings calling for the careful consideration of gynecologic surgeries such as hysterectomy or oophorectomy and their long-term consequences.

  4. Dec. 14, 2021

    OB Nest: Re-imagining low-risk prenatal care

    A new model for low-risk obstetrics care called OB Nest may provide more personalized and less expensive care.

  5. Dec. 14, 2021

    Diagnosis of hypertensive disorders of pregnancy

    Two Mayo Clinic obstetricians discuss an algorithm they developed that proved more effective in diagnosing hypertension in pregnant women.

  6. Dec. 14, 2021

    SARS-CoV-2 infection and COVID-19 during pregnancy

    This article, which appeared in the August 2020 issue of Mayo Clinic Proceedings, examines the potential effects of SARS-CoV-2 infection in pregnancy.

  7. Dec. 14, 2021

    Vulvovaginal issues in mature women

    A gynecologist and a dermatologist at Mayo Clinic in Minnesota offer successful treatment options for postmenopausal women with vulvovaginal conditions.

  8. Dec. 07, 2021

    Treatment options for pelvic organ prolapse

    A Mayo Clinic urogynecologist discusses the latest treatment options for pelvic organ prolapse.

  9. Jan. 12, 2021

    What is a pelvic exenteration?

    Amanika Kumar, M.D., a gynecological oncologist at Mayo Clinic in Rochester, Minnesota, explains the indications and goals of pelvic exenteration surgery: anterior exenteration, posterior exenteration and total exenteration.

  10. Oct. 28, 2020

    Current therapies for patients with overactive bladder

    Overactive bladder and its symptoms can be discouraging and debilitating for patients. Making use of the most current therapies and implementing them in a prescribed sequence, starting with the most conservative measures, is the key to managing the problem.

  11. July 02, 2020

    Advancing fetal surgery for congenital heart defects: Mayo Clinic's approach

    Mayo Clinic pediatric and congenital heart surgeons discuss the benefits of in utero intervention for early treatment of congenital heart defects.

  12. May 28, 2020

    Care for your patients with fibroids at Mayo Clinic

    Learn more about fibroid care within the Division of Gynecology at Mayo Clinic.

  13. Dec. 05, 2019

    Minimally invasive surgery, sentinel lymph node biopsy produce excellent perioperative outcomes for patients with endometrial cancer

    Andrea Mariani, M.D., M.S., a gynecological surgeon at Mayo Clinic in Rochester, Minnesota, discusses the importance of minimally invasive surgery and sentinel nodes in the evolution of surgical treatment of endometrial cancer.

  14. May 13, 2019

    Spina bifida treatment using fetoscope

    Edward S. Ahn, M.D., neurosurgeon, and Rodrigo Ruano, M.D. Ph.D., maternal and fetal medicine surgeon, describe a new treatment for spina bifida using a fetoscope.

  15. May 13, 2019

    Innovations in fetal medicine — Mayo Clinic

    Edward S. Ahn, M.D., neurosurgeon, and Rodrigo Ruano, M.D. Ph.D., maternal and fetal medicine surgeon, describe surgery prior to birth to repair severe congenital anomalies.

  16. Sept. 07, 2018

    Mayo Clinic Minute: Cryopreservation giving kids with cancer a brighter future

    It may seem odd to worry about fertility when we’re talking about childhood cancer. Mayo Clinic’s Zaraq Khan, M.B.B.S. discusses a treatment called gamete cryopreservation.

  17. Aug. 09, 2018

    Fetoscopic laser ablation for placental anastomoses for twin-to-twin transfusion syndrome

    Rodrigo Ruano, M.D., Ph.D., explains twin-to-twin transfusion syndrome, a severe situation with a risk of pregnancy loss in approximately 80% of cases if no prenatal treatment is performed, and the benefits of fetoscopic laser ablation for placental anastomoses.

  18. July 26, 2018

    Clinical trial regarding endometrial cancer and stress urinary incontinence

    Gynecologic oncologist Gretchen E. Glaser, M.D., with Mayo Clinic in Rochester, Minnesota, discusses a study that compares the quality of life and clinical outcomes among women with endometrial cancer and stress urinary incontinence who have concurrent surgery with that of women who do not have concurrent surgery.

  19. July 26, 2018

    Recurrent ovarian cancer: Treatment and clinical trials

    There are many options available to treat recurrent ovarian cancer, even if it has recurred more than once. Recurrence is common in patients with ovarian cancer.

  20. July 26, 2018

    Obesity and endometrial cancer

    Women who are obese are six times more likely to develop endometrial cancer than women who maintain a healthy weight. Amanika Kumar, M.D., discusses the relationship between obesity and endometrial cancer and treatment to ensure long-term, sustainable weight loss.

  21. Aug. 05, 2015

    Mayo researchers developing a new way to screen for endometrial cancer

    Researchers at Mayo Clinic have shown that it is possible to detect endometrial cancer using tumor DNA picked up by ordinary tampons.

  22. Jan. 31, 2014

    Grand Rounds: Management of IBD in Pregnancy

    Sunanda V. Kane, M.D., presents Management of IBD in Pregnancy.

  23. Nov. 19, 2012

    Diagnosing and managing patients with BRCA mutations

    Sandhya Pruthi, M.D., consultant in the Breast Diagnostic Clinic at Mayo Clinic in Rochester, Minnesota, discusses her December 2010 Mayo Clinic Proceedings article on diagnostic and management approaches to patients with BRCA mutations that put them at higher risk of breast and ovarian cancers.